Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer
Caleb Cheng(University of Michigan), Arul M. Chinnaiyan(University of Michigan), Jasmine P. Wisniewski(University of Michigan), Nicholas J. Rossiter(University of Michigan), Xuhong Cao(Howard Hughes Medical Institute), Rupam Bhattacharyya(University of Michigan), Yatrik M. Shah(University of Michigan), Brian Magnuson(University of Michigan), Rahul Mannan(University of Michigan), Dominik Awad(The University of Texas MD Anderson Cancer Center), Yi Bao(Stevens Institute of Technology), Pietro Morlacchi(Agilent Technologies (United States)), Rohit Mehra(University of Michigan–Ann Arbor), Marina Pasca di Magliano(OncoMed (United States)), Tongchen He(University of Michigan), Vaibhav Sahai(University of Michigan–Ann Arbor), Chungen Li(Chinese Academy of Sciences), Costas A. Lyssiotis(University of Michigan), Yang Zheng(University of Jinan), Zhen Wang(Ministry of Education), Yuping Zhang(First Affiliated Hospital of Jiangxi Medical College), Jing Hu(University of Michigan), Ke Ding(University of Illinois Urbana-Champaign), Lanbo Xiao(University of Michigan), Yuanyuan Qiao(University of Michigan)
Cited by 5
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k